Monoclonal Antibody for COVID Gets FDA Emergency Use Authorization

The FDA on Tuesday granted emergency use authorization to Inflarx NV's monoclonal antibody for the treatment of hospitalized COVID patients.
Reuters Health Information

source https://www.medscape.com/viewarticle/990441?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?